<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>8049329</identifier>
<setSpec>0212-7199</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Puigddevall Gallego, V</dc:author>
<dc:author>Laudo Pardos, C</dc:author>
<dc:author>San Martín Barrio, L</dc:author>
<dc:description xml:lang="en">Diabetics patients have a greater risk of morbi-mortality associated to macrovascular disease, which may show as ischemic cardiopathy, stroke and peripheric vascular disease. The high atherogenesis in these patients. Consequently, the therapeutical goals aimed to the reduction of plasmatic lipids must be stricter among the diabetic population and, especially, among women, that among non-diabetic subjects. The first therapeutical step should be to reach a proper metabolic control through diet, exercise and, if necessary, insulin or oral antidiabetics. If these measures are not enough, hypolipemic drugs should be added.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1993 Dec </dc:date>
<dc:title xml:lang="es">Detección y manejo de los trastornos lipídicos en el paciente diabético.</dc:title>
<dc:title xml:lang="en">[Detection and management of lipid disorders in the diabetic patient].</dc:title>
<dc:publisher>Anales de medicina interna (Madrid, Spain : 1984)</dc:publisher>
</metadata>
</record>
</pubmed-document>
